Drug Type Small molecule drug |
Synonyms Tao 191, Tao191 |
Mechanism μ opioid receptor agonists(Mu opioid receptor agonists), σ1 receptor antagonists(Sigma opioid receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | CN | 01 Nov 2022 |